Correlations Between TET2 Mutation and Clinicohematologic Parameters in Myeloproliferative Neoplasms

被引：0

作者：

Ha, Jung Sook ^{[1
]}

Lee, Jae Hee ^{[1
]}

Park, Sung Gyun ^{[1
]}

Ryoo, Nam Hee ^{[1
]}

Jeon, Dong Suk ^{[2
]}

Kim, Jae Ryong ^{[2
]}

Do, Young Rok ^{[3
]}

Kim, Jin Young ^{[4
]}

Kwon, Ki Young ^{[5
]}

Kim, Ji Yoon ^{[6
]}

Suh, Jang Soo ^{[7
]}

机构：

[1] Keimyung Univ, Sch Med, Dept Lab Med, Taegu, South Korea

[2] Keimyung Univ, Sch Medice, Dept Lab Med, Taegu, South Korea

[3] Keimyung Univ, Sch Med, Dept Internal Med, Div Hematol Oncol, Taegu, South Korea

[4] Keimyung Univ, Dongsan Med Ctr, Dept Internal Med, Div Hemato Oncol, Taegu, South Korea

[5] Keimyung Univ, Sch Medine, Dept Internal Med, Div Hematol Oncol, Taegu, South Korea

[6] Keimyung Univ, Sch Medice, Dept Pediat Hematol Oncol, Taegu, South Korea

[7] Kyungpook Natl Univ Hosp, Taegu, South Korea

来源：

BLOOD | 2012年 / 120卷 / 21期

关键词：

D O I：

10.1182/blood.V120.21.1455.1455

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

1455

引用

页数：2

共 50 条

[31] LNK mutation studies in blast-phase myeloproliferative neoplasms, and in chronic-phase disease with TET2, IDH, JAK2 or MPL mutations
Pardanani, A.
Lasho, T.
Finke, C.
Oh, S. T.
Gotlib, J.
Tefferi, A.
LEUKEMIA, 2010, 24 (10) : 1713 - 1718
[32] SRSF2 AND TET2 CO-MUTATION SKEW HAEMATOPOIESIS IN MYELODYSPLASTIC NEOPLASMS (MDNS)
Liang, Y.
Hu, F.
Li, X.
Robert, G.
Chen, S.
LEUKEMIA RESEARCH, 2023, 128
[33] Detection of mutant TET2 in myeloid malignancies other than myeloproliferative neoplasms: CMML, MDS, MDS/MPN and AML
Tefferi, A.
Lim, K-H
Abdel-Wahab, O.
Lasho, T. L.
Patel, J.
Patnaik, M. M.
Hanson, C. A.
Pardanani, A.
Gilliland, D. G.
Levine, R. L.
LEUKEMIA, 2009, 23 (07) : 1343 - 1345
[34] Detection of mutant TET2 in myeloid malignancies other than myeloproliferative neoplasms: CMML, MDS, MDS/MPN and AML
A Tefferi
K-H Lim
O Abdel-Wahab
T L Lasho
J Patel
M M Patnaik
C A Hanson
A Pardanani
D G Gilliland
R L Levine
Leukemia, 2009, 23 : 1343 - 1345
[35] TET2 Mutation Associated Clonal Hematopoiesis is Linked to a TET2 Polymorphism in Acute Myeloid Leukemia Patients
Brauer, Dominic
Grimm, Juliane
Jentzsch, Madlen
Bill, Marius
Goldmann, Karoline
Schulz, Julia
Niederwieser, Dietger
Platzbecker, Uwe
Schwind, Sebastian
ONCOLOGY RESEARCH AND TREATMENT, 2020, 43 : 108 - 109
[36] TET2 gene sequencing may be helpful for myeloproliferative neoplasm diagnosis
Verger, Emmanuelle
Andreoli, Annalisa
Chomienne, Christine
Kiladjian, Jean-Jacques
Cassinat, Bruno
BRITISH JOURNAL OF HAEMATOLOGY, 2014, 165 (03) : 416 - 419
[37] TET2 mutation as prototypic clonal hematopoiesis lesion ☆
Guarnera, Luca
Jha, Babal K.
SEMINARS IN HEMATOLOGY, 2024, 61 (01) : 51 - 60
[38] Familial myeloid malignancies with germline TET2 mutation
Nicolas Duployez
Laure Goursaud
Laurène Fenwarth
Claire Bories
Alice Marceau-Renaut
Thomas Boyer
Elise Fournier
Olivier Nibourel
Catherine Roche-Lestienne
Guillemette Huet
David Beauvais
Céline Berthon
Nathalie Cambier
Bruno Quesnel
Claude Preudhomme
Leukemia, 2020, 34 : 1450 - 1453
[39] Familial myeloid malignancies with germline TET2 mutation
Duployez, Nicolas
Goursaud, Laure
Fenwarth, Laurene
Bories, Claire
Marceau-Renaut, Alice
Boyer, Thomas
Fournier, Elise
Nibourel, Olivier
Roche-Lestienne, Catherine
Huet, Guillemette
Beauvais, David
Berthon, Celine
Cambier, Nathalie
Quesnel, Bruno
Preudhomme, Claude
LEUKEMIA, 2020, 34 (05) : 1450 - 1453
[40] TET2 Mutation Associated with Organ Infiltrations in ATLL
Kameda, Takuro
Shide, Kotaro
Kamiunten, Ayako
Tahira, Yuki
Akizuki, Keiichi
Sekine, Masaaki
Hidaka, Tomonori
Kubuki, Yoko
Hidaka, Michihiro
Utsunomiya, Atae
Ohshima, Takayuki
Kataoka, Keisuke
Ogawa, Seishi
Shimoda, Kazuya
BLOOD, 2018, 132

← 1 2 3 4 5 →